Polypharmacy in the ElderlyPolypharmacy in the Elderly
Marc Evans M. Abat, M.D., FPCP, FPSGM
Internal Medicine-Geriatric Medicine
Marc Evans M. Abat, M.D., FPCP, FPSGM
Internal Medicine-Geriatric Medicine
Objectives
• Definition of polypharmacy
• Prevalence
• Consequences
• Pharmacology and Aging
• Specific Examples
• Interventions
Definitions
• Polypharmacy– The use of more than 5 medications, some of
which may be clinically inappropriate– The number may not be as indicative of its
presence-all may be appropriate; however the more drugs are taken, the higher are the chances for its occurrence
– Leads to profound consequences in the elderly population
Prevalence• As much as 25% of the overall population
(Chumney et al., 2006)• For those >65 years old, prevalence increases
to 50%– 44% males, 56% females– 12% of both sexes > 10 drugs per day
• Prevalence may also be dependent on comorbidity– More drugs among diabetics than age or sex matched
non-diabetics (Good, 2002)• Other predictors include number of starting
drugs, CAD, diabetes, and use of medications without indications (Veehof et al. 2000)
Consequences
Adverse Drug Reactions (ADRs) which may include:
– Drug-drug interactions – Drug-disease interactions – Drug-food interactions– Drug side effects– Drug toxicity
• May increase from 7% in those using 2 drugs to 50% in those using 5 and 100% in those using > 10 (Lin 2003; Brazeau 2001)
Quality of Life
• In ambulatory elderly: 35% of experience ADRs and 29% require medical intervention
• In nursing facilities: 2/3 of residents experience ADRs and 1in 7 of there require hospitalization
• Up to 30% of elderly hospital admissions involve ADRs
• Linked to preventable geriatric syndromesFick 2003. Arch Int Med.
Economic
• In 2000: ADRs caused 10,600 deaths
• Annual cost of $85 billion
• $76.6 billion in ambulatory care
• $20 billion in hospitals
• $4 billion in SNF
Fick 2003. Arch Int Med.
Pharmacokinetics and Aging
• characterization and mathematical description of the absorption, distribution, metabolism, and excretion of drugs, their by-products, and other substances of biologic interest as affected by the elderly body
– Absorption – Distribution– Metabolism – Excretion
Absorption• Age-relatedAge-related gastrointestinal tract and skin
changes seem to be of minor clinical significance for medication usage– Decrease in small intestine surface area– Increase in gastric pH
• Medical conditions (e.g. achlorhydria), other medications or feedings may modify absorption– vitamin B12 in atrophic gastritis– PPIs with sucralfate– Amoxicillin with food
Distribution• Age-related changes
– Decrease in lean body weight– Decrease in total body water(10-15%)– Increased percentage body fat (~15-30%)– Increased fat:water ratio– Decreased plasma proteins, especially albumin
• Occurrence of heart failure, kidney disease with resulting water retention
• Increase in volume of distribution for lipophilic drugs– sedatives that penetrate CNS– Leads to longer half-lives (Linjakumpu 2003)
• Metabolic capacity of phase I reactions decrease
• Phase II reactions are largely unaffected • Greater, active, free concentration in
highly protein-bound drugs
Metabolism• some overall decline in liver metabolic
capacity due to decreased liver mass and hepatic blood flow– Highly variable, no good estimation algorithm– Minimal clinical manifestations
• Concurrent drug use may affect metabolism in both directions
• No formula to estimate this effect
Renal Elimination • Age-related decrease in renal blood flow• GFR decreases by 8 mL/min/1.73
m2/decade • Decreased lean body mass leads to
decreased creatinine production– Serum creatinine not reliable– Need to estimate creatinine clearance and
adjust medications accordingly (i.e. use Cockroft-Gault or MDRD)
Pharmacodynamics and Aging• Effect of the drug on the body with regard
to aging
• Generally, lower drug doses are required to achieve the same effect with advancing age.– Receptor numbers, affinity, or post-receptor
cellular effects may change.– Changes in homeostatic mechanisms can
increase or decrease drug sensitivity.
Inappropriate Medications: Beers Criteria• One of the most, if not the widely used
consensus data for inappropriate medication use in the elderly
• Latest revision in 2003• Covers 2 statements regarding drug use in
elderly:– Those inappropriate for the elderly in general– Those inappropriate for the elderly with regard
to specific conditions
Vitamin and Herbal Use in Older Adults• Highly prevalent among older adults
– 77% in Johnson and Wyandotte county community dwelling elderly
• Generally not reported to the physician
• serious drug interactions possible:– Warfarin, gingko biloba, vitamin E
Non-adherence to Medication Regimens• related to both physician and patient factors
– Large number of medications– Expensive medications – Complex or frequently changing schedule – Adverse reactions– Confusion about brand name/trade name– Difficult-to-open containers– Rectal, vaginal, SQ modes of administration– Limited patient understanding
Geriatric Prescribing Principles• First consider non-drug therapies• Match drugs to specific diagnoses• Try to give medications that will treat more than
condition• Reduce meds when ever possible• Avoid using a drug to treat side effects of another • Review meds regularly (at least q3 months)• Avoid drugs with similar actions / same class• Clearly communicate with pt and caregivers• Consider cost of meds
CARE: Avoiding Polypharmamcy• Caution and Compliance
– Understand side effect profiles– Identify risk factors for an ADR– Consider a risk to benefit ratio– Keep dosing simple- QD or BID– Ask about compliance
CARE: Avoiding Polypharmamcy• Adjust the Dose
– Start low and go slow- titrate– Consider the pharmacokinetics and
pharmacodynamics of the medication
CARE: Avoiding Polypharmamcy• Review Regimen Regularly
– Avoid automatic refills– Look for other sources of medications- OTC– Caution with multiple providers– Don’t use medications to treat side effects of
other meds– Choose drugs discontinue or substitute safer
medications
CARE: Avoiding Polypharmamcy• Educate
– All medicines, even over-the-counter, have adverse effects-report all products used
– Talk to your patient about potential ADRs– Warn them for potential side effects and report
symptoms– Educate the family and caregiver– Ask pharmacist for help identifying interactions – Assist your patient in making and updating a
medication list- personal medical record– Avoid seeing multiple physicians– Do not use medications from others
Personal Health Record
• It will reduce polypharmacy and ADRs
• Multiple specialist involved in care
• Transitions in care from independent living, hospitals, nursing homes and assisted living facilities
• Great aid in emergency care
• Provides the patient with more piece of mind…
Personal Health Record Includes:• Patient identifying information
• Doctors contacts
• Caregiver contacts
• Past Medical History and Allergies
• List of all medications, dose, reason they are taking it and whether it is new
NAME PHONE: ( )
PHONE: ( )
MEDICATION NAME
REASON FOR USE
DESCRIBE OR TAPE MEDICINE
HERE
DOCTOR
PHARMACIST
WHEN TO TAKE MEDICINE SPECIAL NOTES
REMEMBER BRING THIS CHART TO ALL DOCTOR APPOINTMENTS
INCLUDE ALL THE MEDICATIONS YOU ARE TAKINGDO NOT CHANGE THE WAY YOU TAKE THE MEDICATIONS WITHOUT CALLING THE DOCTOR
DO NOT SHARE MEDICATIONS